read : Merck & co TOP SCIENTIST plans major changes for drug research !!!!!!!!
"speed up experimental products in vaccines and viral treatments , including the liver infection HEP C and HIV ...............!!!!!!!!!!!
obvious indeed !!! Kim said "partnerships" , that is more then 1 for sure !!! Save bet for our company , many products , many deals , many dollars and for many years cash flow from their technology..............!!!
In a way, I hope Kim doesn't partner many more products. The real cash comes from self-development but you need the cash to do that. So my hopes are for one more deal. I sort of hope they license out influenza (I actually feel that's their weakest program) and keep hiv, hep C, HPV. That's my bias...
Partnering is good. Let Inovio create the meds and liscense them off, let them create good medicine and focus on good medicine. Don't be greedy, let these companies deal with marketing, manufacturing and distribution. If there stuff pays off, plenty of money to go around. Invest in INO and the companies liscening there meds. Win-Win.